Open access
Aug 2026
Telmisartan Repurposing Targets Novel Biomarkers for Precision Colorectal Cancer Therapy
Telmisartan is a promising candidate for drug repurposing for CRC treatment and capable of modulating selected novel biomarkers CLUH and SLC11A2, according to in silico predicted deleterious mutations.
Sarah Hunachagi, H. H. Alqudihi, S. Abdulazeez et al.
· Pharmaceutics · 0 citations